297 related articles for article (PubMed ID: 9263143)
1. Concentrations and origins of soluble interleukin 6 receptor-alpha in serum and synovial fluid.
Desgeorges A; Gabay C; Silacci P; Novick D; Roux-Lombard P; Grau G; Dayer JM; Vischer T; Guerne PA
J Rheumatol; 1997 Aug; 24(8):1510-6. PubMed ID: 9263143
[TBL] [Abstract][Full Text] [Related]
2. Soluble interleukin 6 (IL-6) receptor and IL-6 levels in serum and synovial fluid of patients with different arthropathies.
Usón J; Balsa A; Pascual-Salcedo D; Cabezas JA; Gonzalez-Tarrio JM; Martín-Mola E; Fontan G
J Rheumatol; 1997 Nov; 24(11):2069-75. PubMed ID: 9375862
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation.
Kotake S; Sato K; Kim KJ; Takahashi N; Udagawa N; Nakamura I; Yamaguchi A; Kishimoto T; Suda T; Kashiwazaki S
J Bone Miner Res; 1996 Jan; 11(1):88-95. PubMed ID: 8770701
[TBL] [Abstract][Full Text] [Related]
4. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
[TBL] [Abstract][Full Text] [Related]
5. Levels of hepatocyte growth factor in synovial fluid and serum of patients with rheumatoid arthritis and release of hepatocyte growth factor by rheumatoid synovial fluid cells.
Yukioka K; Inaba M; Furumitsu Y; Yukioka M; Nishino T; Goto H; Nishizawa Y; Morii H
J Rheumatol; 1994 Dec; 21(12):2184-9. PubMed ID: 7699616
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptor.
Peake NJ; Khawaja K; Myers A; Nowell MA; Jones SA; Rowan AD; Cawston TE; Foster HE
Rheumatology (Oxford); 2006 Dec; 45(12):1485-9. PubMed ID: 16690760
[TBL] [Abstract][Full Text] [Related]
7. Soluble IL-6 receptors (sIL-6R) in hematological patients receiving immunotherapy with IL-2/IFN-alpha or donor lymphocytes following bone marrow transplantation.
Toren A; Novick D; Ackerstein A; Or R; Slavin S; Nagler A
Bone Marrow Transplant; 1996 Oct; 18(4):721-4. PubMed ID: 8899186
[TBL] [Abstract][Full Text] [Related]
8. IL-6 and soluble IL-6 receptor levels change differently after surgery both in the blood and in the operative field.
Hisano S; Sakamoto K; Ishiko T; Kamohara H; Ogawa M
Cytokine; 1997 Jun; 9(6):447-52. PubMed ID: 9199879
[TBL] [Abstract][Full Text] [Related]
9. Effect of soluble interleukin-6 receptor alpha and interleukin-6 secreted by polymorphonuclear leukocytes on tumor necrosis factor-alpha expression and its production by peripheral blood mononuclear cells.
Jablonska E
Mediators Inflamm; 2002 Oct; 11(5):325-8. PubMed ID: 12467526
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of cytokine receptors sTNF-R55, sTNF-R75, and sIL-2R in psoriatic arthritis synovial fluid.
Partsch G; Wagner E; Leeb BF; Dunky A; Steiner G; Smolen JS
J Rheumatol; 1998 Jan; 25(1):105-10. PubMed ID: 9458212
[TBL] [Abstract][Full Text] [Related]
11. Extravasation into synovial tissue induces CCL20 mRNA expression in polymorphonuclear neutrophils of patients with rheumatoid arthritis.
Schlenk J; Lorenz HM; Haas JP; Herrmann M; Hohenberger G; Kalden JR; Röllinghoff M; Beuscher HU
J Rheumatol; 2005 Dec; 32(12):2291-8. PubMed ID: 16331752
[TBL] [Abstract][Full Text] [Related]
12. Rheumatoid synovial fluid contains bioactive leukemia inhibitory factor with cartilage degrading activity--another target for chondroprotective intervention.
Bell MC; Carroll GJ
J Rheumatol; 2000 Feb; 27(2):332-8. PubMed ID: 10685793
[TBL] [Abstract][Full Text] [Related]
13. Macrophage migration inhibitory factor upregulates angiogenic factors and correlates with clinical measures in rheumatoid arthritis.
Kim HR; Park MK; Cho ML; Yoon CH; Lee SH; Park SH; Leng L; Bucala R; Kang I; Choe J; Kim HY
J Rheumatol; 2007 May; 34(5):927-36. PubMed ID: 17407222
[TBL] [Abstract][Full Text] [Related]
14. Soluble interleukin-6 receptor (sIL-6R) in cerebrospinal fluid of patients with inflammatory and non inflammatory neurological diseases.
Michalopoulou M; Nikolaou C; Tavernarakis A; Alexandri NM; Rentzos M; Chatzipanagiotou S; Cambouri C; Vassilopoulos D
Immunol Lett; 2004 Jul; 94(3):183-9. PubMed ID: 15275965
[TBL] [Abstract][Full Text] [Related]
15. Increased levels of interleukin 33 in sera and synovial fluid from patients with active rheumatoid arthritis.
Matsuyama Y; Okazaki H; Tamemoto H; Kimura H; Kamata Y; Nagatani K; Nagashima T; Hayakawa M; Iwamoto M; Yoshio T; Tominaga S; Minota S
J Rheumatol; 2010 Jan; 37(1):18-25. PubMed ID: 19918048
[TBL] [Abstract][Full Text] [Related]
16. Increased synovial fluid levels of interleukin-12, sCD25 and sTNF-RII/sTNF-RI ratio delineate a cytokine pattern characteristic of immune arthropathies.
Ribbens C; André B; Kaye O; Kaiser MJ; Bonnet V; de Groote D; Franchimont N; Malaise MG
Eur Cytokine Netw; 2000 Dec; 11(4):669-76. PubMed ID: 11125312
[TBL] [Abstract][Full Text] [Related]
17. Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis.
De Benedetti F; Massa M; Pignatti P; Albani S; Novick D; Martini A
J Clin Invest; 1994 May; 93(5):2114-9. PubMed ID: 8182142
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 8 and monocyte chemoattractant protein-1 in patients with juvenile rheumatoid arthritis. Relation to onset types, disease activity, and synovial fluid leukocytes.
De Benedetti F; Pignatti P; Bernasconi S; Gerloni V; Matsushima K; Caporali R; Montecucco CM; Sozzani S; Fantini F; Martini A
J Rheumatol; 1999 Feb; 26(2):425-31. PubMed ID: 9972980
[TBL] [Abstract][Full Text] [Related]
19. Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis.
Nowell MA; Richards PJ; Fielding CA; Ognjanovic S; Topley N; Williams AS; Bryant-Greenwood G; Jones SA
Arthritis Rheum; 2006 Jul; 54(7):2084-95. PubMed ID: 16802343
[TBL] [Abstract][Full Text] [Related]
20. Signal through gp130 activated by soluble interleukin (IL)-6 receptor (R) and IL-6 or IL-6R/IL-6 fusion protein enhances ex vivo expansion of human peripheral blood-derived hematopoietic progenitors.
Kimura T; Wang J; Minamiguchi H; Fujiki H; Harada S; Okuda K; Kaneko H; Yokota S; Yasukawa K; Abe T; Sonoda Y
Stem Cells; 2000; 18(6):444-52. PubMed ID: 11072033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]